NASDAQ Biotechnology Index
The NASDAQ Biotechnology Index is a stock market index made up of securities of NASDAQ-listed companies classified according to the Industry Classification Benchmark as either the Biotechnology or the Pharmaceutical industry. A list of the 225 components of the index is published .
Criteria
In order to remain included within the index, the components must meet the following criteria:- The security U.S. listing must be exclusively on the NASDAQ National Market.
- The issuer of the security must be classified according to the Industry Classification Benchmark as either Biotechnology or Pharmaceuticals.
- The security may not be issued by an issuer currently in bankruptcy proceedings.
- The security must have a market capitalization of at least $200 million.
- The security must have an average daily trading volume of at least 100,000 shares.
- The issuer of the security may not have entered into a definitive agreement or other arrangement which would likely result in the security no longer being Index.
- The issuer of the security may not have annual financial statements with an audit opinion that is currently withdrawn.
- The issuer of the security must have "seasoned" on NASDAQ or another recognized market for at least 6 months; in the case of spin-offs, the operating history of the spin-off will be considered.